Article

barrons.com on 2020-05-06 17:27

Alexion Pharmaceuticals Beats Earnings Estimates but Cuts Guidance

Alexion reported revenue for the first quarter of 2020 of $1.4 billion, 27% higher than a year earlier, and earnings per share of $3.22. But it cut ...

Related news